Cargando…

149* 2009 H1N1 influenza A in cystic fibrosis patients. A French collaborative study

Detalles Bibliográficos
Autores principales:	Bucher, J., Hubert, D., Bellon, G., Deneuville, E., Delaisi, B., Corvol, H., Boussaud, V, Bremont, F., Ramadour, M., Petit, I., Renouil, M., Vodoff, M.V., Troussier, F., Vallier, C., Remus, N., Bassinet, L., Grenet, D., Leruez, M., Launay, O., Lortholary, O., Sermet-Gaudelus, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. Published by Elsevier B.V. 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129987/ http://dx.doi.org/10.1016/S1569-1993(11)60165-3

Ejemplares similares

Lessons from a French collaborative case–control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy
por: Bucher, Julie, et al.
Publicado: (2016)

Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach
por: d'Alessandro, Eugenie, et al.
Publicado: (2012)

The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2006)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Evaluation de la technique d'utilisation de la chambre d'inhalation avec masque facial dans le traitement de l'asthme
por: Vodoff, M.V., et al.
Publicado: (1999)

Study of $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm decay chain
por: Cabrera, J A, et al.
Publicado: (1992)

Decay chain $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm
por: Cabrera, J A, et al.
Publicado: (1991)

Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, I., et al.
Publicado: (2018)

Mucoviscidosis: fisiopatología, genética, aspectos clínicos y terapéuticos
por: Noël, S., et al.
Publicado: (2020)

In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2007)

The N = 83 nucleus 149Dy from Gamow-Teller decay of its 11/2- and 1/2+ 149Ho parents
por: Menegazzo, R, et al.
Publicado: (1994)

Emission channeling experiments from the decay of $^{149}$Gd to $^{149}$Eu in GaN
por: De Vries, B, et al.
Publicado: (2003)

149th SPSC Meeting
Publicado: (2023)

149th LHCC Meeting
Publicado: (2022)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge
por: Zajac, Miroslaw, et al.
Publicado: (2021)

Lower Respiratory Tract Infection in a Renal Transplant Recipient: Do not Forget Metapneumovirus
por: Noel, N., et al.
Publicado: (2012)

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2021)

Gamow-Teller strength and particle-phonon states in $^{149}$Dy from decay of its 11/2$^{-}$ and 1/2$^{+}$ $^{149}$Ho
por: Menegazzo, R, et al.
Publicado: (1990)

Terbium-149 for targeted alpha therapy
por: Grundler, Pascal, et al.
Publicado: (2023)

Minutes of the 149th Meeting of the LHCC
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2022)

Terbium-149 for targeted alpha therapy
por: Borgna, Francesca, et al.
Publicado: (2021)

Health Tract, No. 149: Diphtherial Disease
Publicado: (1863)

Health Tract, No. 149: Diphtherial Disease
Publicado: (1865)

Functional Analysis of the Ser149/Thr149 Variants of Human Aspartylglucosaminidase and Optimization of the Coding Sequence for Protein Production
por: Banning, Antje, et al.
Publicado: (2017)

Evaluation of the antibacterial effects and mechanism of Plantaricin 149 from Lactobacillus plantarum NRIC 149 on the peri-implantitis pathogens
por: Lin, Xiaolong, et al.
Publicado: (2021)

Unsolved severe chronic rhinosinusitis elucidated by extensive CFTR genotyping
por: Degrugillier, Fanny, et al.
Publicado: (2019)

Gamow-Teller strength and particle-phonon states in $^{149}$Dy from decay of its 11/2$^{-}$ and 1/2$^{+}$ $^{149}$Ho parents
por: Menegazzo, R, et al.
Publicado: (1989)

Évolution épidémique et déterminants de l’infection par le SARS-CoV-2 chez le personnel hospitalier : comparaison d’un centre adulte et d’un centre pédiatrique
por: Contejean, A., et al.
Publicado: (2020)

La democracia y los hacendistas /
por: Delaisi, Francis, 1873-1947
Publicado: (1911)

Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
por: Saussereau, Emilie Lyne, et al.
Publicado: (2013)

β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
por: Zampoli, Marco, et al.
Publicado: (2022)

IAU Colloquium 149 : the Stellar Populations of Galaxies
por: Barbuy, B, et al.
Publicado: (1992)

Defect and diffusion forum vols 148-149
por: Fisher, David J
Publicado: (1997)

149 HCV AND lymphoma: Genetic and epigenetic factors
por: Zignego, AL, et al.
Publicado: (2014)

Targeted cancer therapy: the potential role of terbium-149
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1996)

Isomerization and Aggregation of the Solar Cell Dye D149
por: El-Zohry, Ahmed, et al.
Publicado: (2012)

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
por: Müller, Cristina, et al.
Publicado: (2016)

Contribution of the Tyr-1 in Plantaricin149a to Disrupt Phospholipid Model Membranes
por: Lopes, José L. S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t286913f2jdbnqbmusj7d0hoi8